| Bioactivity | N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively[1]. |
| Target | EC50: 3.5 nM (FPR1), 6.7 μM (FPR2), 0.88 μM (FPR2-D2817.32G) |
| Name | N-Formyl-Met-Leu-Phe-Lys |
| CAS | 67247-11-4 |
| Sequence | Formyl-Met-Leu-Phe-Lys |
| Shortening | Formyl-MLFK |
| Formula | C27H43N5O6S |
| Molar Mass | 565.73 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. He HQ, et al. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. |
N-Formyl-Met-Leu-Phe-Lys
CAS: 67247-11-4 F: C27H43N5O6S W: 565.73
N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.